openPR Logo
Press release

Oxycodone Drugs Market Size Worth USD 8.29 Billion By 2032, At a Booming 5.4% Growth Rate

Oxycodone Drugs Market Size Worth USD 8.29 Billion By 2032, At

๐Ž๐ฑ๐ฒ๐œ๐จ๐๐จ๐ง๐ž ๐ƒ๐ซ๐ฎ๐ ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐Ž๐ฏ๐ž๐ซ๐ฏ๐ข๐ž๐ฐ:

Oxycodone is a powerful opioid analgesic used for the management of moderate to severe pain. It is often prescribed for conditions such as post-surgical pain, cancer-related pain, and chronic pain conditions. Oxycodone works by binding to opioid receptors in the brain and spinal cord, altering the perception of pain.

The global oxycodone drugs market size is expected to reach USD 8.29 billion by 2032, according to a new study by Polaris Market Research. The report "Oxycodone Drugs Market Share, Size, Trends, Industry Analysis Report, By Drug Type (Short-acting, Long-acting); By Dosage Form; By Distribution Channel; By Region; Segment Forecast, 2024- 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Rising incidence of chronic pain disease such as cancer, rheumatoid arthritis, lower back pain, and fibromyalgia is the primary contributor for the oxycodone market expansion. Moreover, the unresponsiveness shown by other medications for the treatment of severe pain management has increased the demand for oxycodone drugs. Furthermore, promising results of these drugs and benefits associated with the extended release oxycodone drugs has increased its prescription volumes. Additionally, better compliance and convenience of less-frequent dosage intervals offered by oxycodone drugs will fuel the market growth in the coming years.

๐„๐ฑ๐ฉ๐ฅ๐จ๐ซ๐ž ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐๐ƒ๐… ๐จ๐Ÿ ๐ญ๐ก๐ž ๐‘๐ž๐ฉ๐จ๐ซ๐ญ @ https://www.polarismarketresearch.com/industry-analysis/oxycodone-drugs-market/request-for-sample

The advent of extended-release capsules coupled with the high prevalence of severe pain among adults are also propelling the market growth. Moreover, the patents owned by market players coupled with their increasing expenses on marketing and promotion will contribute to the market growth. For instance, Collegium Pharmaceutical's Xtampza ER has patent protection until 2036.

The promising results shown by the oxycodone drugs over other opioid medications is also driving the market growth. Moreover, the advent of new drugs with advancements in drug delivery systems such as extended-release formulations will provide long-term opportunity for the oxycodone drugs market growth. The ability of oxycodone to lower the severe pain after surgery coupled with an increasing number of surgical procedures are expected to support the market expansion.

The widespread acceptance of oxycodone drugs as a pain-relieving medication and growing need for oxycodone for the pain management after surgeries are the factors propelling the market growth. Moreover, the strong focus of companies on the regulatory approvals in untapped markets will positively influence the market growth. Furthermore, lack of physical activities, tobacco usage, and obesity are increasing the number of patients suffering from chronic pain. For instance, according to the World Obesity Atlas 2023 Report by the World Obesity Federation, the number of people with overweight or obesity worldwide is expected to increase to 4.0 billion, from 2.6 billion in 2020. Such obese people requiring pain management medications will drive the market growth during the forecast period.

๐†๐ซ๐จ๐ฐ๐ญ๐ก ๐ƒ๐ซ๐ข๐ฏ๐ž๐ซ๐ฌ:

๐ˆ๐ง๐œ๐ซ๐ž๐š๐ฌ๐ข๐ง๐  ๐๐ซ๐ž๐ฏ๐š๐ฅ๐ž๐ง๐œ๐ž ๐จ๐Ÿ ๐‚๐ก๐ซ๐จ๐ง๐ข๐œ ๐๐š๐ข๐ง ๐‚๐จ๐ง๐๐ข๐ญ๐ข๐จ๐ง๐ฌ:

The growing prevalence of chronic pain conditions, such as osteoarthritis, back pain, and neuropathic pain, has contributed to the demand for effective pain management medications. Oxycodone, being a potent analgesic, is prescribed in cases where other pain relief measures may be insufficient.

๐‘๐ข๐ฌ๐ข๐ง๐  ๐ˆ๐ง๐œ๐ข๐๐ž๐ง๐œ๐ž ๐จ๐Ÿ ๐‚๐š๐ง๐œ๐ž๐ซ ๐š๐ง๐ ๐‘๐ž๐ฅ๐š๐ญ๐ž๐ ๐๐š๐ข๐ง:

Oxycodone is frequently used in the management of cancer-related pain. As the incidence of cancer continues to rise globally, particularly with an aging population, the demand for effective pain relief medications like oxycodone is expected to increase.

๐„๐ฑ๐ฉ๐š๐ง๐ฌ๐ข๐จ๐ง ๐จ๐Ÿ ๐’๐ฎ๐ซ๐ ๐ข๐œ๐š๐ฅ ๐๐ซ๐จ๐œ๐ž๐๐ฎ๐ซ๐ž๐ฌ:

Surgical procedures often result in post-operative pain, and oxycodone is commonly prescribed to manage pain in the immediate post-surgical period. The increasing number of surgical interventions, including orthopedic, dental, and other procedures, contributes to the demand for oxycodone drugs.

๐๐ฎ๐ฒ ๐ญ๐ก๐ข๐ฌ ๐๐ซ๐ž๐ฆ๐ข๐ฎ๐ฆ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก ๐‘๐ž๐ฉ๐จ๐ซ๐ญ: https://www.polarismarketresearch.com/buy/3295/2

๐€๐ฉ๐ฉ๐ฅ๐ข๐œ๐š๐ญ๐ข๐จ๐ง๐ฌ:

๐๐š๐ข๐ง ๐Œ๐š๐ง๐š๐ ๐ž๐ฆ๐ž๐ง๐ญ ๐ข๐ง ๐‚๐ก๐ซ๐จ๐ง๐ข๐œ ๐‚๐จ๐ง๐๐ข๐ญ๐ข๐จ๐ง๐ฌ:

Oxycodone is widely used for pain management in chronic conditions where persistent pain is a significant aspect, such as in osteoarthritis, rheumatoid arthritis, and neuropathic pain. The extended-release formulations of oxycodone are often employed for continuous pain relief.

๐๐จ๐ฌ๐ญ-๐’๐ฎ๐ซ๐ ๐ข๐œ๐š๐ฅ ๐๐š๐ข๐ง ๐Œ๐š๐ง๐š๐ ๐ž๐ฆ๐ž๐ง๐ญ:

Oxycodone is commonly prescribed for post-surgical pain management. It helps alleviate acute pain following various surgical procedures, ensuring patient comfort during the recovery period. The immediate-release formulations are often utilized for this purpose.

๐‚๐š๐ง๐œ๐ž๐ซ-๐‘๐ž๐ฅ๐š๐ญ๐ž๐ ๐๐š๐ข๐ง ๐‘๐ž๐ฅ๐ข๐ž๐Ÿ:

Oxycodone plays a crucial role in palliative care for cancer patients by providing effective pain relief for cancer-related pain. The opioid's analgesic properties make it valuable in improving the quality of life for individuals undergoing cancer treatments or in advanced stages of the disease.

It's important to note that the use of opioids, including oxycodone, is associated with concerns related to opioid misuse, addiction, and overdose. Healthcare professionals need to carefully assess patients for their pain management needs and weigh the risks and benefits of opioid therapy.

๐Ž๐ฑ๐ฒ๐œ๐จ๐๐จ๐ง๐ž ๐ƒ๐ซ๐ฎ๐ ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐‡๐ข๐ ๐ก๐ฅ๐ข๐ ๐ก๐ญ๐ฌ

The long-acting segment dominated the market, owing to its benefits for improving pain management and reducing pain intensity variations.

The capsules segment is expected to expand at the highest CAGR, owing to the emergence of extended release capsules.
Hospital segment held the largest market share, owing to the increasing number of surgical procedures and rising hospital admissions.

North America dominated the market, owing to the large volume of oxycodone prescriptions and rising incidences of chronic pain diseases.

The market players include Collegium Pharmaceutical, Mundipharma International, Sun Pharmaceutical Industries Ltd., Endo International plc, and Mallinckrodt.

๐๐จ๐ฅ๐š๐ซ๐ข๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก ๐ก๐š๐ฌ ๐ฌ๐ž๐ ๐ฆ๐ž๐ง๐ญ๐ž๐ ๐ญ๐ก๐ž ๐จ๐ฑ๐ฒ๐œ๐จ๐๐จ๐ง๐ž ๐๐ซ๐ฎ๐ ๐ฌ ๐ฆ๐š๐ซ๐ค๐ž๐ญ ๐ซ๐ž๐ฉ๐จ๐ซ๐ญ ๐›๐š๐ฌ๐ž๐ ๐จ๐ง ๐๐ซ๐ฎ๐  ๐ญ๐ฒ๐ฉ๐ž, ๐๐จ๐ฌ๐š๐ ๐ž ๐Ÿ๐จ๐ซ๐ฆ, ๐๐ข๐ฌ๐ญ๐ซ๐ข๐›๐ฎ๐ญ๐ข๐จ๐ง ๐œ๐ก๐š๐ง๐ง๐ž๐ฅ, ๐š๐ง๐ ๐ซ๐ž๐ ๐ข๐จ๐ง:

๐Ž๐ฑ๐ฒ๐œ๐จ๐๐จ๐ง๐ž ๐ƒ๐ซ๐ฎ๐ ๐ฌ, ๐ƒ๐ซ๐ฎ๐  ๐“๐ฒ๐ฉ๐ž ๐Ž๐ฎ๐ญ๐ฅ๐จ๐จ๐ค (๐‘๐ž๐ฏ๐ž๐ง๐ฎ๐ž - ๐”๐’๐ƒ ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง, ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ— - ๐Ÿ๐ŸŽ๐Ÿ‘๐Ÿ)

Short-acting
Long-acting

๐Ž๐ฑ๐ฒ๐œ๐จ๐๐จ๐ง๐ž ๐ƒ๐ซ๐ฎ๐ ๐ฌ, ๐ƒ๐จ๐ฌ๐š๐ ๐ž ๐…๐จ๐ซ๐ฆ ๐Ž๐ฎ๐ญ๐ฅ๐จ๐จ๐ค (๐‘๐ž๐ฏ๐ž๐ง๐ฎ๐ž - ๐”๐’๐ƒ ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง, ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ— - ๐Ÿ๐ŸŽ๐Ÿ‘๐Ÿ)

Tablet
Capsule
Injection

๐Ž๐ฑ๐ฒ๐œ๐จ๐๐จ๐ง๐ž ๐ƒ๐ซ๐ฎ๐ ๐ฌ, ๐ƒ๐ข๐ฌ๐ญ๐ซ๐ข๐›๐ฎ๐ญ๐ข๐จ๐ง ๐‚๐ก๐š๐ง๐ง๐ž๐ฅ ๐Ž๐ฎ๐ญ๐ฅ๐จ๐จ๐ค (๐‘๐ž๐ฏ๐ž๐ง๐ฎ๐ž - ๐”๐’๐ƒ ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง, ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ— - ๐Ÿ๐ŸŽ๐Ÿ‘๐Ÿ)

Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

๐‚๐จ๐ง๐ญ๐š๐œ๐ญ ๐ฎ๐ฌ ๐Ÿ๐จ๐ซ ๐’๐ฉ๐ž๐œ๐ข๐š๐ฅ ๐ƒ๐ข๐ฌ๐œ๐จ๐ฎ๐ง๐ญ ๐š๐ง๐ ๐๐ซ๐ข๐œ๐ข๐ง๐  @ https://www.polarismarketresearch.com/industry-analysis/oxycodone-drugs-market/request-for-discount-pricing

๐“๐ก๐ž ๐†๐ž๐จ๐ ๐ซ๐š๐ฉ๐ก๐ข๐œ๐š๐ฅ ๐€๐ง๐š๐ฅ๐ฒ๐ฌ๐ข๐ฌ ๐‚๐จ๐ฏ๐ž๐ซ๐ฌ ๐…๐จ๐ฅ๐ฅ๐จ๐ฐ๐ข๐ง๐  ๐Š๐ž๐ฒ ๐‘๐ž๐ ๐ข๐จ๐ง๐ฌ:

North America (United States, Canada, and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and the Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and the rest of South America)

The Middle East and Africa (Saudi Arabia, United Arab Emirates, Egypt, South Africa, and the Rest of the Middle East and Africa)

๐„๐ฑ๐ฉ๐ฅ๐จ๐ซ๐ž ๐Œ๐จ๐ซ๐ž:

๐Ÿ“๐† ๐…๐ข๐ฑ๐ž๐ ๐–๐ข๐ซ๐ž๐ฅ๐ž๐ฌ๐ฌ ๐€๐œ๐œ๐ž๐ฌ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ: https://www.linkedin.com/pulse/5g-fixed-wireless-access-market-revolutionizing-xy3pf

๐‹๐ญ๐ž ๐€๐ง๐ ๐Ÿ“๐† ๐๐ซ๐จ๐š๐๐œ๐š๐ฌ๐ญ ๐Œ๐š๐ซ๐ค๐ž๐ญ: https://www.linkedin.com/pulse/lte-5g-broadcast-market-transforming-media-delivery-wpjyf

๐Ÿ“๐† ๐“๐ž๐ฌ๐ญ๐ข๐ง๐  ๐„๐ช๐ฎ๐ข๐ฉ๐ฆ๐ž๐ง๐ญ ๐Œ๐š๐ซ๐ค๐ž๐ญ: https://www.linkedin.com/pulse/5g-testing-equipment-market-pioneering-innovation-network-yby9f

๐‹๐ข๐ญ๐ก๐ข๐ฎ๐ฆ-๐ˆ๐จ๐ง ๐๐š๐ญ๐ญ๐ž๐ซ๐ฒ ๐Œ๐š๐ซ๐ค๐ž๐ญ: https://www.linkedin.com/pulse/lithium-ion-battery-market-powering-future-clean-energy-cdndf

๐‚๐จ๐ง๐ญ๐š๐œ๐ญ ๐ˆ๐ง๐Ÿ๐จ:

Polaris Market Research
30 Wall Street, 8th Floor,
New York City, NY 10005,
United States
Phone:+1-929 297-9727
Email: sales@polarismarketresearch.com

๐€๐›๐จ๐ฎ๐ญ ๐”๐ฌ:

Polaris Market Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Polaris Market Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We at Polaris are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defence, among different ventures present globally.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Oxycodone Drugs Market Size Worth USD 8.29 Billion By 2032, At a Booming 5.4% Growth Rate here

News-ID: 3369773 • Views: โ€ฆ

More Releases from Polaris Market Research & Consulting

Granite Market Projected to Reach USD 6.63 Billion by 2034, Growing at a CAGR of 5.2%
Granite Market Projected to Reach USD 6.63 Billion by 2034, Growing at a CAGR of โ€ฆ
Polaris Market Research has released new insights into the Granite market, highlighting key developments, evolving trends, and growth prospects across major regions and segments. The report delivers an in-depth analysis of market dynamics, competitive shifts, and strategic outlooks to support informed decision-making for businesses and investors. Market at a Glance In 2024, the market was valued at USD 3.99 billion and is anticipated to grow to USD 6.63 Billion by 2034. Itโ€ฆ
Molecular Diagnostics for Sexually Transmitted Diseases Market to Reach USD 7.85 Billion by 2034, Growing at a CAGR of 7.5%
Molecular Diagnostics for Sexually Transmitted Diseases Market to Reach USD 7.85 โ€ฆ
Polaris Market Research announces the release of its latest study on the Molecular Diagnostics For Sexually Transmitted Diseases market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape. According to the findings, the market stood at 3.82 billion in 2024 and is expected toโ€ฆ
Higher Alpha Olefins Market Projected to Hit USD 20.01 Billion by 2034, Expanding at a CAGR of 6.8%
Higher Alpha Olefins Market Projected to Hit USD 20.01 Billion by 2034, Expandin โ€ฆ
Polaris Market Research announces the release of its latest study on the Higher Alpha Olefins market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape. According to the findings, the market stood at 10.39 billion in 2024 and is expected to reach 20.01 billionโ€ฆ
Direct Oral Anticoagulants (DOACs) Device Market to Reach USD 64.83 Billion by 2034, Growing at a CAGR of 7.44%
Direct Oral Anticoagulants (DOACs) Device Market to Reach USD 64.83 Billion by 2 โ€ฆ
Polaris Market Research announces the release of its latest study on the Direct Oral Anticoagulants (DOACs) Device market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape. According to the findings, the market stood at 31.67 billion in 2024 and is expected to reachโ€ฆ

All 5 Releases


More Releases for Oxycodone

Orthopedic Disorder Surge Fuels Oxycodone Market Growth Driving Market Accelerat โ€ฆ
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Oxycodone Drugs Market Size By 2025? The market for oxycodone drugs has seen a substantial expansion in recent years. Its market size is set to rise from $5.62 billion in 2024 to $5.98 billion in 2025, marking a compound annual growth rate (CAGR) of 6.4%.โ€ฆ
Oxycodone Drugs Top Companies Data Analysis to 2031
The Oxycodone Drugs Market is expected to register a CAGR of 5.4% from 2025 to 2031. The report is segmented By Product (Short-acting, and Long-acting), Application (Pain Management, and De-addiction), Distribution Channel (Hospital Pharmacies, and Retail Pharmacies). The global analysis is further broken-down at regional level and major countries. The Report Offers the Value in USD for the above analysis and segments. Download PDF Brochure at: https://www.theinsightpartners.com/sample/TIPRE00040896/?utm_source=OpenPR&utm_medium=10413 The List of Companies Teva Pharmaceuticalโ€ฆ
Orthopedic Disorder Surge Fuels Oxycodone Market Growth: A Significant Driver Pr โ€ฆ
The Oxycodone Drugs Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Oxycodone Drugs Market Size and Projected Growth Rate? The oxycodone drugs market has experienced strong growth over the years. It is forecasted to rise from $5.62 billion in 2024 to $6.04 billionโ€ฆ
Oxycodone Market is Booming Worldwide | Pfizer, Apotex, Mylan
The Latest Released Oxycodone market study has evaluated the future growth potential of Global Oxycodone market and provides information and useful stats on market structure and size. The report is intended to provide market intelligence and strategic insights to help decision-makers take sound investment decisions and identify potential gaps and growth opportunities. Additionally, the report also identifies and analyses changing dynamics, and emerging trends along with essential drivers, challenges, opportunities,โ€ฆ
Orthopedic Disorder Surge Fuels Oxycodone Market Growth Driver: Leading Transfor โ€ฆ
What market dynamics are playing a key role in accelerating the growth of the oxycodone drugs market? The high prevalence of orthopedic disorders is projected to drive the oxycodone drug market. These disorders, which affect the bones, joints, muscles, and soft tissues, cause significant pain and impair mobility. Oxycodone drugs are commonly used to manage acute and chronic pain related to orthopedic conditions. The Institute for Health Metrics and Evaluation (IHME)โ€ฆ
Key Oxycodone Drugs Market Trend for 2025-2034: Focus On Developing Immediate-Re โ€ฆ
What Is the Future Outlook for the Oxycodone Drugs Market's Size and Growth Rate? The market for oxycodone drugs has experienced robust growth in the past few years. The size of the market is projected to escalate from $5.62 billion in 2024 to $6.04 billion in 2025, with a compound annual growth rate (CAGR) of 7.4%. The historical period's growth is mainly due to an intensive marketing strategy for OxyContin.โ€ฆ